BIOLASE, Inc. (BIOLQ)

OTCMKTS · Delayed Price · Currency is USD
0.0090
-0.0045 (-33.48%)
Apr 4, 2025, 4:00 PM EST
-95.11%
Market Cap 395.25K
Revenue (ttm) 46.03M
Net Income (ttm) -15.97M
Shares Out 36.60M
EPS (ttm) -0.71
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 11
Average Volume 68,032
Open 0.0080
Previous Close 0.0135
Day's Range 0.0080 - 0.0120
52-Week Range 0.0040 - 0.2000
Beta 0.58
RSI 57.10
Earnings Date Mar 21, 2025

About BIOLASE

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; di... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1984
Employees 157
Stock Exchange OTCMKTS
Ticker Symbol BIOLQ
Full Company Profile

Financial Performance

In 2023, BIOLASE's revenue was $49.16 million, an increase of 1.45% compared to the previous year's $48.46 million. Losses were -$37.62 million, 30.4% more than in 2022.

Financial Statements

News

There is no news available yet.